AU2001268326A1 - Peptides with physiological activity - Google Patents

Peptides with physiological activity

Info

Publication number
AU2001268326A1
AU2001268326A1 AU2001268326A AU6832601A AU2001268326A1 AU 2001268326 A1 AU2001268326 A1 AU 2001268326A1 AU 2001268326 A AU2001268326 A AU 2001268326A AU 6832601 A AU6832601 A AU 6832601A AU 2001268326 A1 AU2001268326 A1 AU 2001268326A1
Authority
AU
Australia
Prior art keywords
peptides
physiological activity
physiological
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001268326A
Inventor
Chanda Zaveri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001268326A1 publication Critical patent/AU2001268326A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001268326A 2000-06-14 2001-06-12 Peptides with physiological activity Abandoned AU2001268326A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21185900P 2000-06-14 2000-06-14
US60211859 2000-06-14
US09879666 2001-06-12
US09/879,666 US6767891B2 (en) 2000-06-14 2001-06-12 Peptides with wound healing activity
PCT/US2001/018830 WO2001096527A2 (en) 2000-06-14 2001-06-12 Peptides with physiological activity

Publications (1)

Publication Number Publication Date
AU2001268326A1 true AU2001268326A1 (en) 2001-12-24

Family

ID=26906527

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001268326A Abandoned AU2001268326A1 (en) 2000-06-14 2001-06-12 Peptides with physiological activity

Country Status (5)

Country Link
US (4) US6767891B2 (en)
EP (1) EP1296704A4 (en)
AU (1) AU2001268326A1 (en)
CA (1) CA2413141C (en)
WO (1) WO2001096527A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1613369A4 (en) * 2003-03-31 2008-10-01 Regenerx Biopharmaceuticals Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives
AU2004283067A1 (en) 2003-10-10 2005-05-06 Oryxe Transdermal high and low molecular weight compounds
US20090053194A1 (en) * 2003-12-22 2009-02-26 Regenerx Biopharmaceuticals, Inc. Method of treating or preventing biological or immunological responses to a reactive chemical or biological or toxic agent
KR101532778B1 (en) * 2005-03-23 2015-06-30 오클루스 이노바티브 사이언시즈 인코포레이티드 Method of treating second and third degree burns using oxidative reductive potential water solution
US20070004036A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for keratinocyte culture
US20070128685A1 (en) * 2005-07-01 2007-06-07 Rodolfo Faudoa Methods and compositions for cell culture
US20070003541A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
US20070092494A1 (en) * 2005-10-26 2007-04-26 Biomet Manufacturing Corp. Composition for wound healing using lyophilized skin or skin-derived collagen
US20070196357A1 (en) 2006-01-20 2007-08-23 Oculus Innovative Sciences, Inc. Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution
WO2009033816A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of the combination of thymosin beta 10 and thymosin alpha 1 peptides as a therapeutic agent
RU2010113975A (en) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) (D-Leu) -HISTRILIN AS A THERAPEUTIC
US10342825B2 (en) 2009-06-15 2019-07-09 Sonoma Pharmaceuticals, Inc. Solution containing hypochlorous acid and methods of using same
US10279007B2 (en) 2010-11-15 2019-05-07 Oxygenetix Institute, Inc. Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs
US9468654B1 (en) 2014-04-02 2016-10-18 Ali Razavi Drug delivery compositions and methods
WO2021173160A1 (en) 2020-02-28 2021-09-02 Chanda Zaveri Hair growth and scalp preparations
WO2022178005A1 (en) 2021-02-17 2022-08-25 Oxion Dental, Llc Stabilized active oxygen-generating antiseptic compositions, irrigation solutions, and articles

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148788A (en) * 1978-01-23 1979-04-10 Hoffmann-La Roche Inc. Synthesis of thymosin α1
DE2919592A1 (en) * 1979-05-15 1981-01-15 Max Planck Gesellschaft METHOD FOR PRODUCING THYMOSINE ALPHA 1 AND DERIVATIVES THEREOF
US4470926A (en) * 1980-01-18 1984-09-11 Max-Planck-Gesellschaft zur F/o/ rderung der Wissenschaften e.V. Medicaments containing thymosin alpha 1 fragments and having an immunostimulant action, and fragments of thymosin alpha 1
DE3100974A1 (en) * 1980-01-18 1982-01-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Medicaments having immunoregulating action which contain thymosin alpha 1 fragments, and thymosin alpha 1 fragments
US4612365A (en) * 1980-03-25 1986-09-16 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften Medicaments containing alpha 1-thymosin and having an immuno regulatory action and alpha 1-thymosin fragments
US4816566A (en) * 1983-06-01 1989-03-28 Hoffmann-La Roche, Inc. Polypeptides having interferon activity
US4614731A (en) * 1983-09-15 1986-09-30 Hoffmann-La Roche Inc. Peptide having immunopotentiating activity similar to thymosin alpha1
US4659694A (en) * 1983-10-27 1987-04-21 Hoffmann-La Roche Inc. Prothymosin alpha
US4696915A (en) * 1984-05-25 1987-09-29 Hoffmann-La Roche Inc. Parathymosin alpha
US4716148A (en) * 1984-08-13 1987-12-29 Hoffman-La Roche Inc. Prothymosin alpha
US4855407A (en) * 1985-04-11 1989-08-08 Alpha-1 Biomedicals, Inc. Solid phase process for synthesizing peptides
US5686116A (en) * 1990-01-12 1997-11-11 New York Society For The Relief Of The Ruptured And Crippled, Maintaining The Hospital For Special Surgery Methods of enhancing repair, healing and augmentation of bone implants
US5459237A (en) * 1990-02-08 1995-10-17 Magainin Pharmaceuticals Inc. Peptide compositions and uses therefor
US5273963A (en) * 1991-03-29 1993-12-28 The George Washington University Compositions and methods for treating small cell and nonsmall cell lung cancers
WO1993005802A1 (en) * 1991-09-13 1993-04-01 Magainin Pharmaceuticals Inc. Biologically active amphiphilic peptide compositions and uses therefor
US5654274A (en) * 1992-06-01 1997-08-05 Magainin Pharmaceuticals, Inc. Biologically active peptides having N-terminal substitutions
CN1058500C (en) * 1993-02-03 2000-11-15 施塞克龙药品公司 Thymosin alpha-1 derivatives
US6331409B1 (en) * 1996-11-21 2001-12-18 The Regents Of The University Of Michigan Methods and compositions for wound healing
FR2758830B1 (en) * 1997-01-29 1999-04-02 Soc D Domaines Viticoles Marte POLYPEPTIDE COMPOUNDS AND NUCLEOTIDE SEQUENCES FOR PROMOTING EUTYPIOSIS RESISTANCE IN PLANTS
GB9702943D0 (en) * 1997-02-13 1997-04-02 Univ Manchester Wound healing
US6121236A (en) * 1998-03-24 2000-09-19 The Children's Medical Center Corporation Multivalent ligands which modulate angiogenesis
US6204360B1 (en) * 1999-12-16 2001-03-20 Usa Universe Bioengineering, Inc. Retro-inverso thymosin alpha 1 hybrids

Also Published As

Publication number Publication date
EP1296704A4 (en) 2005-04-27
US20040067884A1 (en) 2004-04-08
US20020082196A1 (en) 2002-06-27
WO2001096527A3 (en) 2002-05-02
CA2413141C (en) 2014-01-07
US6767891B2 (en) 2004-07-27
CA2413141A1 (en) 2001-12-20
EP1296704A2 (en) 2003-04-02
WO2001096527A2 (en) 2001-12-20
US20050250685A1 (en) 2005-11-10
US20050176636A1 (en) 2005-08-11

Similar Documents

Publication Publication Date Title
AU5259100A (en) Medicament
AU3081601A (en) Skin attachment member
AU2001260327A1 (en) Chair
AU5318700A (en) Ergonomic chair
AU2101101A (en) Flexible armrest construction
AU4439701A (en) Patient support
AU2001268326A1 (en) Peptides with physiological activity
AU1557901A (en) Chair
AU2001247334A1 (en) Novel peptides with anti-hypertensive activity
AU1608201A (en) Human zven proteins
AU2575000A (en) Collagen-binding physiologically active polypeptide
AU2001286721A1 (en) Human interleukin-four induced protein
AU2001263850A1 (en) Pyrimidine-sulfonamides having endothelin-antagonist activity
AU2067501A (en) Human oxidoreductase proteins
AU2002227925A1 (en) Human beta-defensin-3
AU3978700A (en) Medical use
AU7470400A (en) Cathelicidin-derived peptides with broad spectrum antimicrobial activity
AU2001282880A1 (en) Proteins with integrin-like activity
AU2001252200A1 (en) Chair
AU4456800A (en) Human hac3
AU1043601A (en) Medical use
AU1581301A (en) Human chemokine beta-13
AU2001236101A1 (en) Polypeptide having phosphodiesterase activity
AU1526501A (en) Chair
AU7420800A (en) Medical use